三尖瓣修复与置换治疗感染性心内膜炎的全国性队列研究
基于台湾全民健康保险研究数据库2000至2013年704例因感染性心内膜炎行三尖瓣手术的患者,其中412例(58.5%)接受修复、292例(41.5%)接受置换。经倾向评分逆概率加权后,两组院内死亡率无显著差异,但修复组围术期并发症更少、ICU及住院时间更长、费用更高,且远期全因再入院、不良肝脏结局再入院、新永久起搏器植入及全因死亡风险均更低。推荐对具备手术指征的感染性心内膜炎患者采取修复优先策略。
要点
- 感染性心内膜炎行三尖瓣手术时,修复较置换的围术期并发症更少。
- 修复组远期全因死亡风险显著低于置换组(HR 0.60,95%CI 0.51-0.71)。
- 修复组新永久起搏器植入风险显著低于置换组(subdistribution HR 0.27,95%CI 0.15-0.48)。
核心结论
- 对于感染性心内膜炎,三尖瓣修复与更好的早期和远期结局相关。
- 推荐对具备三尖瓣手术指征的感染性心内膜炎患者采取修复优先策略。
研究设计与样本
- 全国性人群队列研究,纳入台湾全民健康保险研究数据库2000至2013年因感染性心内膜炎行三尖瓣手术的704例患者。
- 412例(58.5%)行三尖瓣修复,292例(41.5%)行三尖瓣置换,分析围术期与远期结局。
- 采用倾向评分逆概率加权减少混杂。
主要发现
- 逆概率加权后,两组院内死亡率无显著差异。
- 修复组围术期并发症(大量输血、新发透析、深部伤口感染)发生率更低,但ICU及住院时间更长、住院费用更高。
- 修复组全因再入院风险更低(subdistribution HR 0.68,95%CI 0.60-0.78;P < 0.001)。
- 修复组不良肝脏结局再入院风险更低(subdistribution HR 0.75,95%CI 0.58-0.97;P = 0.025)。
- 修复组新永久起搏器植入风险更低(subdistribution HR 0.27,95%CI 0.15-0.48;P < 0.001),全因死亡风险更低(HR 0.60,95%CI 0.51-0.71;P < 0.001)。
临床怎么用
- 对感染性心内膜炎需三尖瓣手术的患者,可优先考虑修复策略以改善远期结局。
- 修复策略可能增加ICU及住院时间与费用,但围术期并发症更少。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The aim of this study was to compare the outcomes of tricuspid valve (TV) repair versus replacement for patients with infective endocarditis (IE). METHODS: In this nationwide population-based cohort study, we identified 704 patients from Taiwan National Health Insurance Research Database who underwent TV surgery due to IE between 2000 and 2013. Of them, 412 (58.5%) underwent TV repair and 292 (41.5%) underwent TV replacement, and their perioperative and late outcomes were analysed. Confounding was reduced using the inverse probability of treatment weighting on propensity score. RESULTS: After inverse probability of treatment weighting, the in-hospital mortality rate between the 2 groups was not significantly different. However, patients who received TV repair had lower rates of perioperative complications, including massive blood transfusion, de novo dialysis and deep wound infection; longer ICU and hospital stays; and higher hospital cost. Regarding late outcomes, TV repair was associated with lower risks of all-cause readmission [subdistribution hazard ratio (HR) 0.68, 95% confidence interval (CI) 0.60-0.78; P < 0.001], readmission for adverse liver outcomes (subdistribution HR 0.75, 95% CI 0.58-0.97; P = 0.025), new permanent pacemaker implantation (subdistribution HR 0.27, 95% CI 0.15-0.48; P < 0.001) and all-cause mortality (HR 0.60, 95% CI 0.51-0.71; P < 0.001) than TV replacement. CONCLUSIONS: For IE, TV repair is associated with better early and late outcomes than TV replacement. A repair-first strategy is recommended for patients with IE for whom TV surgery is indicated.
引用
- Lee HA, Chou AH, Wu VC, et al. Nationwide cohort study of tricuspid valve repair versus replacement for infective endocarditis. Eur J Cardiothorac Surg. 2021. PMID: 33156910. doi:10.1093/ejcts/ezaa390
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。